期刊
METABOLISM-CLINICAL AND EXPERIMENTAL
卷 134, 期 -, 页码 -出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.metabol.2022.155250
关键词
Proteome modulation; Molecular pathways; Cardiotoxicity; Anticancer agents; Chemotherapy
资金
- FCT-Fundacao para a Ciencia e a Tecnologia [UIDP/04378/2020, UIDB/04378/2020, LA/P/0140/2020]
- Associate Laboratory Institute for Health and Bioeconomy-i4HB
- European Social Fund (FSE) [SFRH/BD/138202/2018]
- FCT
- FCT, IP [SFRH/BHD/110001/2015, DL57/2016/CP1334/CT0006]
This systematic review aims to provide an integrative perspective of the molecular mechanisms underlying the toxicity of anticancer agents on heart muscle using mass spectrometry (MS)-based proteomics. The results show that different anticancer agents have different mechanisms of cardiac toxicity, but the specific modulation is not completely elucidated.
Several anticancer agents have been associated with cardiac toxic effects. The currently proposed mechanisms to explain cardiotoxicity differ among anticancer agents, but in fact, the specific modulation is not completely elucidated. Thus, this systematic review aims to provide an integrative perspective of the molecular mechanisms underlying the toxicity of anticancer agents on heart muscle while using a high-throughput technology, mass spectrometry (MS)-based proteomics. A literature search using PubMed database led to the selection of 27 studies, of which 13 reported results exclusively on animal models, 13 on cardiomyocyte-derived cell lines and only one included both animal and a cardiomyocyte line. The reported anticancer agents were the proteasome
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据